{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:22:17Z","timestamp":1775247737604,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:00:00Z","timestamp":1430611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13722-015-0034-5","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T03:35:57Z","timestamp":1430537757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Factors associated with willingness to take extended release naltrexone among injection drug users"],"prefix":"10.1186","volume":"10","author":[{"given":"Keith","family":"Ahamad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MJ","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha","family":"Uhlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheyenne","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd P","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,3]]},"reference":[{"key":"34_CR1","unstructured":"The United Nations Office on Drugs and Crime. World Drug Report 2014 2014. Available from: http:\/\/www.unodc.org\/wdr2014\/."},{"key":"34_CR2","unstructured":"National Institues on Drug Abuse. Popping Pills: Prescription Drug Abuse in America. Available from: http:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/infographics\/popping-pills-prescription-drug-abuse-in-america#1."},{"issue":"1","key":"34_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","volume":"132","author":"CM Jones","year":"2013","unstructured":"Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2013United States, 2002\u20132004 and 2008\u20132010. Drug Alcohol Depend. 2013;132(1):95\u2013100.","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"34_CR4","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1111\/add.12266","volume":"108","author":"W Ling","year":"2013","unstructured":"Ling W, Hillhouse M, Ang A, Jenkins J, Fahey J. Comparison of behavioral treatment conditions in buprenorphine maintenance. Addiction. 2013;108(10):1788\u201398.","journal-title":"Addiction"},{"key":"34_CR5","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Library. 2014.","DOI":"10.1002\/14651858.CD002207.pub4"},{"issue":"4","key":"34_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","volume":"93","author":"LA Marsch","year":"1998","unstructured":"Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta\u2010analysis. Addiction. 1998;93(4):515\u201332.","journal-title":"Addiction"},{"key":"34_CR7","volume-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","author":"M Connock","year":"2007","unstructured":"Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor R, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. 2007."},{"issue":"12","key":"34_CR8","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","volume":"68","author":"RD Weiss","year":"2011","unstructured":"Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011;68(12):1238\u201346.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"34_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","volume":"21","author":"JA Peterson","year":"2010","unstructured":"Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O\u2019Grady KE, et al. Why don\u2019t out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy. 2010;21(1):36\u201342.","journal-title":"Int J Drug Policy"},{"issue":"18","key":"34_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","volume":"343","author":"RE Johnson","year":"2000","unstructured":"Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343(18):1290\u20137.","journal-title":"N Engl J Med"},{"issue":"11","key":"34_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","author":"EC Strain","year":"1999","unstructured":"Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate-vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999;281(11):1000\u20135.","journal-title":"JAMA"},{"issue":"5","key":"34_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","volume":"53","author":"W Ling","year":"1996","unstructured":"Ling W, Wesson DR, Charuvastra C, Klett CJ. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry. 1996;53(5):401\u20137.","journal-title":"Arch Gen Psychiatry"},{"key":"34_CR13","volume-title":"Sustained-release naltrexone: novel treatment for opioid dependence","author":"SD Comer","year":"2007","unstructured":"Comer SD, Sullivan MA, Hulse GK. Sustained-release naltrexone: novel treatment for opioid dependence. 2007."},{"key":"34_CR14","doi-asserted-by":"crossref","unstructured":"Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Library. 2011.","DOI":"10.1002\/14651858.CD001333.pub4"},{"issue":"2","key":"34_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","volume":"63","author":"SD Comer","year":"2006","unstructured":"Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2006;63(2):210\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"9776","key":"34_CR16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","volume":"377","author":"E Krupitsky","year":"2011","unstructured":"Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet. 2011;377(9776):1506\u201313.","journal-title":"Lancet"},{"issue":"3","key":"34_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/YCO.0b013e3283386578","volume":"23","author":"EM Krupitsky","year":"2010","unstructured":"Krupitsky EM, Blokhina EA. Long-acting depot formulations of naltrexone for heroin dependence: a review. Curr Opin Psychiatry. 2010;23(3):210\u20134.","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"34_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.psc.2012.03.002","volume":"35","author":"W Ling","year":"2012","unstructured":"Ling W, Mooney L, Wu L-T. Advances in opioid antagonist treatment for opioid addiction. Psychiatr Clin N Am. 2012;35(2):297\u2013308.","journal-title":"Psychiatr Clin N Am"},{"issue":"8","key":"34_CR19","doi-asserted-by":"publisher","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","volume":"11","author":"SA Strathdee","year":"1997","unstructured":"Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59\u201365.","journal-title":"AIDS"},{"issue":"6","key":"34_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","volume":"17","author":"MW Tyndall","year":"2003","unstructured":"Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887\u201393.","journal-title":"AIDS"},{"issue":"12","key":"34_CR21","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3109\/10826084.2011.561516","volume":"46","author":"SE Hadland","year":"2011","unstructured":"Hadland SE, Marshall BD, Kerr T, Zhang R, Montaner JS, Wood E. A comparison of drug use and risk behavior profiles among younger and older street youth. Subst Use Misuse. 2011;46(12):1486\u201394.","journal-title":"Subst Use Misuse"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1471-2458-9-171","volume":"9","author":"T Kerr","year":"2009","unstructured":"Kerr T, Marshall BD, Miller C, Shannon K, Zhang R, Montaner JS, et al. Injection drug use among street-involved youth in a Canadian setting. BMC Public Health. 2009;9:171.","journal-title":"BMC Public Health"},{"issue":"1","key":"34_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1037\/a0013420","volume":"6","author":"JP Fitzgerald","year":"2009","unstructured":"Fitzgerald JP, McCarty D. Understanding attitudes towards use of medication in substance abuse treatment: A multilevel approach. Psychol Serv. 2009;6(1):74\u201384.","journal-title":"Psychol Serv"},{"issue":"3","key":"34_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jsat.2005.02.003","volume":"28","author":"BE Fuller","year":"2005","unstructured":"Fuller BE, Rieckmann T, McCarty D, Smith KW, Levine H. Adoption of naltrexone to treat alcohol dependence. J Subst Abus Treat. 2005;28(3):273\u201380.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"34_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0740-5472(02)00319-7","volume":"24","author":"CP Thomas","year":"2003","unstructured":"Thomas CP, Wallack SS, Lee S, McCarty D, Swift R. Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abus Treat. 2003;24(1):1\u201311.","journal-title":"J Subst Abus Treat"},{"issue":"3","key":"34_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.drugalcdep.2005.05.002","volume":"80","author":"T Kerr","year":"2005","unstructured":"Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend. 2005;80(3):329\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"Supplement 1","key":"34_CR27","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2007.05.007","volume":"91","author":"RS Garfein","year":"2007","unstructured":"Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study\/Drug Users Intervention Trial (CIDUS III\/DUIT). Drug Alcohol Depend. 2007;91(Supplement 1):S4\u201317.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"34_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s10461-013-0693-8","volume":"18","author":"NK Rotondi","year":"2014","unstructured":"Rotondi NK, Strike C, Kolla G, Rotondi MA, Rudzinski K, Guimond T, et al. Transition to injection drug use: the role of initiators. AIDS Behav. 2014;18(3):486\u201394.","journal-title":"AIDS Behav"},{"key":"34_CR29","series-title":"AIDS Care","volume-title":"Risk behaviors for HIV in sexual partnerships of San Francisco injection drug users","author":"YH Chen","year":"2013","unstructured":"Chen YH, McFarland W, Raymond HF. Risk behaviors for HIV in sexual partnerships of San Francisco injection drug users, AIDS Care. 2013."},{"issue":"7","key":"34_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011697","volume":"5","author":"A Palepu","year":"2010","unstructured":"Palepu A, Marshall BD, Lai C, Wood E, Kerr T. Addiction treatment and stable housing among a cohort of injection drug users. PLoS One. 2010;5(7), e11697.","journal-title":"PLoS One"},{"key":"34_CR31","unstructured":"Abuse NIoD. Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES) 2014 [cited 2014 August 18, 2014]. Available from: http:\/\/www.drugabuse.gov\/about-nida\/organization\/cctn\/ctn\/research-studies\/comparing-treatments-hiv-positive-opioid-users-in-integrated-care-effective."},{"issue":"9165","key":"34_CR32","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(98)07026-3","volume":"353","author":"DC Des Jarlais","year":"1999","unstructured":"Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353(9165):1657\u201361.","journal-title":"Lancet"}],"container-title":["Addiction Science & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-015-0034-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13722-015-0034-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-015-0034-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-015-0034-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T12:25:20Z","timestamp":1630585520000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-015-0034-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1186\/s13722-015-0034-5","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,3]]},"assertion":[{"value":"23 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}